close Icon

Idarubicin-anti-CD3 reduces vascular disease in mouse cardiac allografts.

Mottram PL, Han W, Murray-Segal L, Pietersz GA, McKenzie IF

VIEW FULL ARTICLE
  • Journal Transplantation proceedings

  • Published 15 Apr 1999

  • Volume 31

  • ISSUE 1-2

  • Pagination 1414-5

  • DOI 10.1016/s0041-1345(98)02113-7